ArticleProceedings of the National Academy of Sciences of the United States of America2014

Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.

Samuel A Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.